Mental health professionals no longer diagnose ADD. Instead, they diagnose one of three types of ADHD: inattentive, hyperactive-impulsive, or combined. Attention deficit hyperactivity disorder ...

The panel of experts at the ISP felt strongly that localization of pheochromocytoma or paraganglioma should only be initiated if the clinical evidence for the presence of tumor is reasonably ...

The European Commission (EC) has conditionally approved MSD's Welireg, an oral hypoxia-inducible factor-2 alpha (HIF-2α) ...

2019.00867 12 Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol ...

Background Until recently, determining penetrance required large observational cohort studies. Data from the Exome Aggregate Consortium (ExAC) allows a Bayesian approach to calculate penetrance, in ...

Accepted for Priority Review Belzutifan (Merck) Hypoxia-inducible factor inhibitor Treatment of adult and pediatric patients aged 12 years and older with advanced, unresectable, or metastatic ...

or metastatic pheochromocytoma and paraganglioma. sNDA accepted for Priority Review Datopotamab deruxtecan (AstraZeneca and Daiichi Sankyo) TROP2-directed DXd antibody drug conjugate Treatment of ...

Sum of quarterly amounts may not equal year-to-date amounts due to rounding. (1) Only select products are shown. (2) Alliance Revenue represents Merck’s share of profits, which are product sales ...

The previously unrecognized neuronal features and the putative secretory phenotype of STFs set them apart from mesenchymal malignancies and relate them to neuroendocrine malignancies such as ...